Sato Pharmaceutical Inc. recalls Motion Sickness (meclizine hydrochloride) 25 mg tablets, 12-count box, Distributed by Sato Pharmaceutical INC. 20695 S.…
- Recall date
- October 1, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0323-2020
- FDA classification
- Class III
- Brand / firm
- Sato Pharmaceutical Inc.
- Sold / distributed
- Nationwide within the United States, Guam and Saipan
Why it was recalled
Subpotent Drug
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Motion Sickness (meclizine hydrochloride) 25 mg tablets, 12-count box, Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501, NDC 59779-534-01. UPC 050428345535
Get recall alerts
Free email alert whenever Sato Pharmaceutical Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Sato Pharmaceutical Inc.